BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to Hs-578T cell line is 38
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MYC | 7553 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | Western Blotting and RT-PCR followed by SFA | NA | 0.48 | 0.1304 | 28951456 |
| MYC | 7553 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | IF staining followed by SFA | NA | 0.48 | 0.1304 | 34889737 |
| BMI1 | 1066 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | Western Blotting followed by SFA | NA | 0.28 | 0.1135 | 34294320 |
| PROM1 | 9454 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | Western Blotting followed by SFA | NA | 0.28 | 0.7582 | 34294320 |
| PROM1 | 9454 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SFA followed by qPCR | NA | 0.28 | 0.7582 | 30224376 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SP assay followed by SFA and IHC staining | NA | 0.24 | 0.456 | 29981340 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SFA followed by qPCR | NA | 0.24 | 0.456 | 30224376 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | FACs | NA | 0.24 | 0.456 | 29162703 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | Invasion assay followed by SP assay and FACs | NA | 0.24 | 0.456 | 18386134 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SFA followed by FACs | NA | 0.24 | 0.456 | 28951456 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SP assay followed by SFA and IHC staining | NA | 0.24 | 1 | 29981340 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SFA followed by qPCR | NA | 0.24 | 1 | 30224376 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | FACs followed by SFA | NA | 0.24 | 1 | 34294320 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | FACs followed by SFA followed by | NA | 0.24 | 1 | 34344863 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | MACs followed by SFA | NA | 0.24 | 1 | 34715882 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | FACs | NA | 0.24 | 1 | 29162703 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | FACs and SFA | NA | 0.24 | 1 | 29183891 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | FACs followed by SFA | NA | 0.24 | 1 | 29048610 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | Invasion assay followed by SP assay and FACs | NA | 0.24 | 1 | 18386134 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SFA followed by FACs | NA | 0.24 | 1 | 28951456 |
| NANOG | 20857 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | IF staining followed by SFA | NA | 0.24 | 0.5461 | 34889737 |
| NANOG | 20857 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SFA followed by qPCR | NA | 0.24 | 0.5461 | 30224376 |
| POU5F1 | 9221 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | IF staining followed by SFA | NA | 0.24 | 0.6448 | 34889737 |
| POU5F1 | 9221 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SFA followed by qPCR | NA | 0.24 | 0.6448 | 30224376 |
| SOX2 | 11195 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | IF staining followed by SFA | NA | 0.24 | 0.5695 | 34889737 |
| SOX2 | 11195 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SFA followed by qPCR | NA | 0.24 | 0.5695 | 30224376 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.684 | 28976208 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | ALDEFLUOR assay followed by SFA | NA | 0.2 | 0.684 | 34344863 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | FACs | NA | 0.2 | 0.684 | 29162703 |
| B4GALNT1 | 4117 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | qRT-PCR | NA | 0.2 | 0.0042 | 33722905 |
| FOXO3 | 3821 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SFA followed by qPCR | NA | 0.2 | 0.0021 | 30224376 |
| GPNMB | 4462 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SFA followed by qPCR | NA | 0.2 | 0.0021 | 30224376 |
| PIK3CA | 8975 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0032 | 28976208 |
| TWIST1 | 12428 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0191 | 28976208 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | FACs followed by SFA | NA | 0.12 | 0.456 | 34294320 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | FACs followed by SFA | NA | 0.12 | 0.456 | 34344863 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | MACs followed by SFA | NA | 0.12 | 0.456 | 34715882 |
| EPCAM | 11529 | LTM | Triple Negative Breast Cancer | Carcinoma | Hs-578T | NA | SFA followed by FACs | NA | 0.12 | 0.211 | 28951456 |